Inpatient prescribing trends and differences in drug acquisition costs of long-acting injectable subcutaneous risperidone versus paliperidone palmitate: A single-center medication use evaluation.

Saved in:
Bibliographic Details
Title: Inpatient prescribing trends and differences in drug acquisition costs of long-acting injectable subcutaneous risperidone versus paliperidone palmitate: A single-center medication use evaluation.
Authors: Hean AC; (Corresponding author) Assistant Professor of Pharmacy Practice and Administration, Western University of Health Sciences, College of Pharmacy; Pomona, California, ahean@westernu.edu., Wong C; PharmD Candidate 2026, University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, California., Park JH; Pharmacy and Therapeutics Coordinator, University of California, San Diego Health, Department of Pharmacy, San Diego, California., Stevens C; Medication Use Policy and Outcomes Specialist, University of California, San Diego Health, Department of Pharmacy, San Diego, California., Tiefenthaler C; Inpatient Psychiatric Pharmacist, University of California, San Diego Health, Department of Pharmacy, San Diego, California.
Source: The mental health clinician [Ment Health Clin] 2026 Feb 03; Vol. 16 (1), pp. 7-12. Date of Electronic Publication: 2026 Feb 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: American Association of Psychiatric Pharmacists Country of Publication: United States NLM ID: 101728585 Publication Model: eCollection Cited Medium: Internet ISSN: 2168-9709 (Electronic) Linking ISSN: 21689709 NLM ISO Abbreviation: Ment Health Clin Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-9709
DOI:10.9740/mhc.2026.02.007